1-3 of 3
Paolo Anderlini, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Amin M. Alousi, MD, Chitra Hosing, M.D., Rima M. Saliba, PhD., Rosamar B. Valverde, BSN, Farzaneh Maadani, BS, Martin Korbling, M.D., Grace J. Okoroji, MS, Luis E. Fayad, M.D., Anne M. Stachowiak, BS, William D. Erwin, MS, Paolo Anderlini, M.D., Marcos J. de Lima, M.D., Sergio A. Giralt, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Naoto T. Ueno, M.D., Peter W. McLaughlin, M.D., Barbara Pro, M.D., Michael Wang, M.D., Alma Rodriguez, M.D., Fredrick B. Hagemeister, M.D., Homer A. Macapinlac, M.D., Donald A. Podoloff, M.D., Richard E. Champlin, M.D., Issa F. Khouri, M.D.
Journal: Blood
Blood (2007) 110 (11): 620.
https://doi.org/10.1182/blood.V110.11.620.620
Published: 2007
Journal Articles

Immunotherapy with Donor Leukocyte Infusions (DLIS) in Relapsed Hodgkin’s Disease (HD) Following Allogeneic Stem Cell Transplantation (ALLO-SCT): CD3+ Cell Dose, GVHD and Disease Response.

Paolo Anderlini, M.D., Sandra A. Acholonu, Grace-Julia Okoroji, Rima Saliba, Sergio A. Giralt, Naoto Ueno, Michele L. Donato, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2004) 104 (11): 1654.
https://doi.org/10.1182/blood.V104.11.1654.1654
Published: 2004
Journal Articles

Sequential Treatment with Reduced Intensity Allogeneic Stem Cell Transplantation and Imatinib for Chronic Myelogenous Leukemia (CML.

Richard Champlin, M.D., Shubhra Ghosh, M.D., Gloria McCormick, R.N., Borje Andersson, M.D., Ph.D., Marcos de Lima, M.D., Paolo Anderlini, M.D., Muzaffar Qazilbash, M.D., Sergio Giralt, M.D., Jorge Cortes, M.D.
Journal: Blood
Blood (2004) 104 (11): 812.
https://doi.org/10.1182/blood.V104.11.812.812
Published: 2004